Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies

Abstract Measurable residual disease (MRD) assessment has become a cornerstone in the management of acute myeloid leukemia (AML), offering critical prognostic information and guiding post-remission therapy. Conventional MRD detection methods, including multiparameter flow cytometry (MFC), quantitati...

全面介紹

書目詳細資料

Principais autores:	Anamaria Bancos, Andrei Ivancuta, Vlad Moisoiu, Adrian-Bogdan Tigu, Diana Gulei, Madalina Nistor, Cristian-Silviu Moldovan, David Kegyes, Diana Cenariu, Mihnea Zdrenghea, Anca Bojan, Stefania D. Iancu, Nicolae Leopold, Gabriel Ghiaur, Horia Bumbea, Alina Tanase, Hermann Einsele, Stefan O. Ciurea, Ciprian Tomuleasa
格式:	Artigo
語言:	Inglês
出版:	BMC 2025-11-01
叢編:	Biomarker Research
主題:	Minimal residual disease Acute myeloid leukemia SERS DNA methylation profiling
在線閱讀:	https://doi.org/10.1186/s40364-025-00869-w
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!